CoViD-19 (SARS-CoV-2), from diagnosis to vaccine (original) (raw)

Priručnik za komunikaciju o vakcinaciji protiv kovida-19

Konstantinos Armaos

2021

View PDFchevron_right

Determination of antibodies to SARS-CoV-2 in patients with coronavirus infection

George Ignatyev, Сергей Клотченко

Infectious diseases: News, Opinions, Training, 2022

View PDFchevron_right

MIR 19® – world first specific antiviral drug for COVID-19 treatment: development and preclinical studies

Artem Maerle

Immunologiya

View PDFchevron_right

МУЛЬТИСИСТЕМНИЙ ЗАПАЛЬНИЙ СИНДРОМ, АСОЦІЙОВАНИЙ ІЗ SARS-COV-2 У ДИТИНИ

Оксана Боярчук

2021

View PDFchevron_right

Epidemiology and course of infectious diseases during the covid-19 pandemic. Report 2. Interference engaged between SARS-COV-2 and acute respiratory viral infections

Ekaterina Boeva

Russian Journal of Infection and Immunity

View PDFchevron_right

An ELISA Platform for the Quantitative Analysis of SARS-CoV-2 RBD-neutralizing Antibodies As an Alternative to Monitoring of the Virus-Neutralizing Activity

George Skryabin

Acta Naturae

View PDFchevron_right

Laboratory Characteristics of a Multisystem Inflammatory Syndrome Associated with SARS-COV-2 in Children and Their Correction

Лариса Коробко

Health & Education

View PDFchevron_right

Prospects of Pharmacological Intervention in New SARS-CoV-2 Coronavirus and COVID-19 Caused by it

Максим Иванов

ВЕСТНИК ОБРАЗОВАНИЯ И РАЗВИТИЯ НАУКИ РОССИЙСКОЙ АКАДЕМИИ ЕСТЕСТВЕННЫХ НАУК

View PDFchevron_right

ACTIV SARS-CoV-2 registry (Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients). Assessment of impact of combined original comorbid diseases in patients with COVID-19 on the prognosis

D. Ruzanov

Terapevticheskii arkhiv, 2022

View PDFchevron_right

ADAPTATION AND VALIDATION OF THE CORONAVIRUS-19 PHOBIA SCALE (C19P-S) IN RUSSIA

yavuz ercan Gul

2021

View PDFchevron_right

RAACI's and NAEPID's position paper: vaccination of patients with PID and HAE against COVID-19

Daria Fomina

Russian Allergology Journal, 2021

View PDFchevron_right

A rational strategy for the maintenance of antiviral immunity to new SARS-CoV-2 strains

Gaukhar Yusubalieva

Клиническая практика, 2022

View PDFchevron_right

Polymerase chain reaction test for detection of SARS-CoV-2 virus and variants

Shaban Memeti

Archives of Public Health

View PDFchevron_right

Newly diagnosed diseases and the frequency of their occurrence in patients after a new coronavirus infection. Results of an International Register "Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors (ACTIV SARS-CoV-2)" (12-month follow-up)

Abdirashit Maripov

Russian Journal of Cardiology, 2023

View PDFchevron_right

ПОПУЛЯЦИОННЫЙ ИММУНИТЕТ К ВИРУСУ SARS-CоV-2 У ЖИТЕЛЕЙ ИРКУТСКОЙ ОБЛАСТИ В ДИНАМИКЕ РАЗВИТИЯ ЭПИДЕМИЧЕСКОГО ПРОЦЕССА

Константин Корытов

View PDFchevron_right

Распространение вариантов вируса SARS-COV-2, вызывающих озабоченность (VOC) на основе количества их геномов, депонированных в базу данных GISAID за неделю с 24.09.2022 г. по 30.09.2022 г

Ярослав Краснов

View PDFchevron_right

International register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (AKTIV) and the register “Analysis of hospitalizations of comorbid patients infected during the second wave of SARS-CoV-2 outbreak” (AKTIV 2)

D. Ruzanov

Russian Journal of Cardiology

View PDFchevron_right

Biomarkers of inflammation and cytokine storm: a relationship with the production levels of virus-specific IgG isotype antibodies to SARS-CoV-2 N-protein in COVID-19 present and vaccinated persons

Leonid Titov

Doklady of the National Academy of Sciences of Belarus, 2021

View PDFchevron_right

The impact of BMI on the course of the acute SARS-COV-2 infection and the risks that emerge during the first year after the hospital discharge. Subanalysis evidence of the AKTIV and AKTIV 2 registries

Hamlet Hayrapetyan

Problems of Endocrinology

View PDFchevron_right

Гипотеза существования симбиоза между вирусом иммунного апгрейда HIV++ и коронавирусом SARS-CoV-2.

Serge Shavirin

Гипотеза существования симбиоза между вирусом иммунного апгрейда HIV++ и коронавирусом SARS-CoV-2., 2020

View PDFchevron_right

Features of clinical picture of pneumonia caused by SARS-COV-2 virus in children

Daria Khavkina

Medical alphabet, 2021

View PDFchevron_right

Clinical features of post-COVID-19 period. Results of the international register “Dynamic analysis of comorbidities in SARS-CoV-2 survivors (AKTIV SARS-CoV-2)”. Data from 6-month follow-up

D. Ruzanov

Russian Journal of Cardiology

View PDFchevron_right

Preclinical studies of immunogenity, protectivity, and safety of the combined vector vaccine for prevention of the middle east respiratory syndrome

Ilias Esmagambetov

Acta Naturae, 2020

View PDFchevron_right

Intra-laboratory validated “TigraTest® SARS-CoV-2” — test assessing release of interferon gamma in vitro to identify peripheral blood T-lymphocytes specifically responding against SARS-CoV-2 virus antigens

Rahim Shukurov

Russian Journal of Infection and Immunity

View PDFchevron_right

ДОВЕРИЕ КАК СПОСОБ ПРЕОДОЛЕНИЯ КРИЗИСА НА ПРИМЕРЕ КОВИД-19

Svetlana Gurieva

Sovremennye issledovaniya sotsialnykh problem, 2020

View PDFchevron_right

ВОЗМОЖНОСТИ ЛЕЧЕНИЯ ИНФЕКЦИИ COVID-19, ВЫЗВАННОЙ НОВЫМ КОРОНАВИРУСОМ SARS-CoV-2

Alexandr Melnik

View PDFchevron_right

Асоцијација помеѓу АБО крвногрупниот систем и Ковид-19

Nikola Kamcev

2020

View PDFchevron_right

RAACI’s position paper: vaccination of patients with allergic disease PID and HAE against COVID-19

Татьяна Латышева

Rossijskij allergologičeskij žurnal, 2021

View PDFchevron_right

Некоторые патогенетические механизмы кожных изменений у больных Сovid-19

денис усенко

View PDFchevron_right

Распространение вариантов вируса SARS-COV-2, вызывающих озабоченность (VOC) на основе количества их геномов, депонирован-ных в базу данных GISAID за неделю с 03.11.2022 г. по 11.11.2022 г

Александра иванова Иванова

View PDFchevron_right

Clinical features of post-COVID period. Results of an International Register "Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors (ACTIV SARS-CoV-2)" (12-month follow-up)

D. Ruzanov

Russian Journal of Cardiology

View PDFchevron_right